| Record ID | marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:495981420:1375 |
| Source | Western Washington University |
| Download Link | /show-records/marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:495981420:1375?format=raw |
LEADER: 01375cam 2200325 a 4500
001 ocm07960381
008 811130s1981 dcua b f00010 eng d
035 $a(GPO)82002584
040 $aGPO$cGPO$dMvI
043 $an-us---
049 $aXFFA
086 0 $aY 3.T 22/2:2 C 82/no.2/case 11
100 10 $aFineberg, Harvey V
245 10 $aBenefit-and-cost analysis of medical interventions :$bthe case of cimetidine and peptic ulcer disease /$cHarvey V. Fineberg and Laurie A. Pearlman
260 0 $aWashington, D.C. :$bCongress of the U.S., Office of Technology Assessment :$bFor sale by the Supt. of Docs., U.S. G.P.O.,$c1981
300 $aviii, 64 p. :$bill. ;$c26 cm
440 4 $aThe Implications of cost-effectiveness analysis of medical technology.$nBackground paper #2,$pCase studies of medical technologies ;$vcase study #1
500 $a"September 1981."
504 $aBibliography: p. 59-64
500 $a"OTA-BP-H-9(11)"--P. 4 of cover
650 0 $aCimetidine$xCost effectiveness
650 0 $aPeptic ulcer$zUnited States
650 0 $aMedical technology$xCost effectiveness
650 0 $aMedical instruments and apparatus$xCost effectiveness
700 10 $aPearlman, Laurie A
710 10 $aUnited States.$bCongress.$bOffice of Technology Assessment
907 $a.b16617812$bmulti$c-
902 $a071013
998 $b1$c970812$dm$ea$f-$g0
902 $aMarcive